卓正医疗(02677)发布年度业绩，经调整净利润2564.8万元同比增加139.7%

智通财经

Mar 25

智通财经APP讯，卓正医疗(02677)发布截至2025年12月31日止年度业绩，该集团取得收入人民币10.65亿元(单位下同)，同比增加11.1%;净利润1.31亿元，同比增加63.8%;经调整净利润2564.8万元，同比增加139.7%;每股基本盈利9.68元。

2025年，是公司基于外部宏观环境的变化、探索如何激活增长动能的一年。公司以“打造卓越口碑”为战略主线，立足优质医疗服务供给的核心根基，向需求侧深度聚焦，围绕网点升级、医护团队用户思维提升、核心产品竞争力打造、人工智能(AI)+数字化能力建设等方向推进战略落地，实现稳健内生增长;同时在并购整合领域持续积累经验、打磨团队能力，为公司未来发展筑牢坚实基础。

2025年，公司深度洞察并满足客户核心需求，构建稳固的客户关系体系，增强客户信任并向忠实会员群体转化，实现用户长期留存。会员账户数、新会员数量实现稳健增长，新客会员转化率、会员续费率维持较高水平，充分印证会员生态的健康发展及需求侧聚焦的显著成效。口碑推荐是公司一直以来的核心获客方式，核心口碑指标净推荐值(NPS)自86.2同比提升至87.3，维持行业领先水平;销售费用占收入比为1.5%，保持行业低位。彰显公司品牌的强口碑效应与规模化获客优势，为高质量用户增长提供坚实支撑。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2622027905"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2622027905\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2622027905?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-03-25 18:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622027905","market":"fut","top_or_hot":-1,"title":"卓正医疗(02677)发布年度业绩，经调整净利润2564.8万元 同比增加139.7%","media":"智通财经","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/02677\">卓正医疗</a>(02677)发布截至2025年12月31日止年度业绩，该集团取得收入人民币10.65亿元(单位下同)，同比增加11.1%;净利润1.31亿元，同比增加63.8%;经调整净利润2564.8万元，同比增加139.7%;每股基本盈利9.68元。</p><p>2025年，是公司基于外部宏观环境的变化、探索如何激活增长动能的一年。公司以“打造卓越口碑”为战略主线，立足优质医疗服务供给的核心根基，向需求侧深度聚焦，围绕网点升级、医护团队用户思维提升、核心产品竞争力打造、人工智能(AI)+数字化能力建设等方向推进战略落地，实现稳健内生增长;同时在并购整合领域持续积累经验、打磨团队能力，为公司未来发展筑牢坚实基础。</p><p>2025年，公司深度洞察并满足客户核心需求，构建稳固的客户关系体系，增强客户信任并向忠实会员群体转化，实现用户长期留存。会员账户数、新会员数量实现稳健增长，新客会员转化率、会员续费率维持较高水平，充分印证会员生态的健康发展及需求侧聚焦的显著成效。口碑推荐是公司一直以来的核心获客方式，核心口碑指标净推荐值(NPS)自86.2同比提升至87.3，维持行业领先水平;销售费用占收入比为1.5%，保持行业低位。彰显公司品牌的强口碑效应与规模化获客优势，为高质量用户增长提供坚实支撑。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>卓正医疗(02677)发布年度业绩，经调整净利润2564.8万元 同比增加139.7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n卓正医疗(02677)发布年度业绩，经调整净利润2564.8万元 同比增加139.7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-25 18:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1418866.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，卓正医疗(02677)发布截至2025年12月31日止年度业绩，该集团取得收入人民币10.65亿元(单位下同)，同比增加11.1%;净利润1.31亿元，同比增加63.8%;经调整净利润2564.8万元，同比增加139.7%;每股基本盈利9.68元。2025年，是公司基于外部宏观环境的变化、探索如何激活增长动能的一年。公司以“打造卓越口碑”为战略主线，立足优质医疗服务供给的核心根基...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1418866.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02677","symbol_name":"卓正医疗","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1418866.html","article_id":"2622027905","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622027905","pubTimestamp":1774436151,"columns":[{"name":"Data Report","id":30,"label_key":"dataReport"}],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，卓正医疗 发布截至2025年12月31日止年度业绩，该集团取得收入人民币10.65亿元，同比增加11.1%;净利润1.31亿元，同比增加63.8%;经调整净利润2564.8万元，同比增加139.7%;每股基本盈利9.68元。2025年，公司深度洞察并满足客户核心需求，构建稳固的客户关系体系，增强客户信任并向忠实会员群体转化，实现用户长期留存。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"02677":"卓正医疗"},"translate_title":"Zhuozheng Medical (02677) released its annual results, with an adjusted net profit of 25.648 million yuan, a year-on-year increase of 139.7%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02677":1.5},"content_text":"智通财经APP讯，卓正医疗(02677)发布截至2025年12月31日止年度业绩，该集团取得收入人民币10.65亿元(单位下同)，同比增加11.1%;净利润1.31亿元，同比增加63.8%;经调整净利润2564.8万元，同比增加139.7%;每股基本盈利9.68元。2025年，是公司基于外部宏观环境的变化、探索如何激活增长动能的一年。公司以“打造卓越口碑”为战略主线，立足优质医疗服务供给的核心根基，向需求侧深度聚焦，围绕网点升级、医护团队用户思维提升、核心产品竞争力打造、人工智能(AI)+数字化能力建设等方向推进战略落地，实现稳健内生增长;同时在并购整合领域持续积累经验、打磨团队能力，为公司未来发展筑牢坚实基础。2025年，公司深度洞察并满足客户核心需求，构建稳固的客户关系体系，增强客户信任并向忠实会员群体转化，实现用户长期留存。会员账户数、新会员数量实现稳健增长，新客会员转化率、会员续费率维持较高水平，充分印证会员生态的健康发展及需求侧聚焦的显著成效。口碑推荐是公司一直以来的核心获客方式，核心口碑指标净推荐值(NPS)自86.2同比提升至87.3，维持行业领先水平;销售费用占收入比为1.5%，保持行业低位。彰显公司品牌的强口碑效应与规模化获客优势，为高质量用户增长提供坚实支撑。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}